Two Sigma Investments
TCON

Two Sigma Investments’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Two Sigma Investments’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,741
Closed -$15K – 3433
2024
Q1 		$15K Buy
+1,741
New +$8.31K ﹤0.01% 2941
2022
Q4 		– Sell
-2,009
Closed -$67K – 3141
2022
Q3 		$67K Sell
2,009
-55
-3% -$2.1K ﹤0.01% 2277
2022
Q2 		$83K Sell
2,064
-2,061
-50% -$79.8K ﹤0.01% 2290
2022
Q1 		$217K Sell
4,125
-5,895
-59% -$296K ﹤0.01% 2320
2021
Q4 		$555K Sell
10,020
-5,969
-37% -$381K ﹤0.01% 3145
2021
Q3 		$1.24M Buy
15,989
+3,486
+28% +$295K ﹤0.01% 2413
2021
Q2 		$1.62M Sell
12,503
-2,971
-19% -$411K ﹤0.01% 2060
2021
Q1 		$2.55M Buy
15,474
+3,256
+27% +$627K 0.01% 1520
2020
Q4 		$2.86M Buy
+12,218
New +$1.7M 0.01% 1267
2020
Q3 		– Sell
-4,436
Closed -$174K – 3668
2020
Q2 		$174K Buy
4,436
+2,652
+149% +$105K ﹤0.01% 2684
2020
Q1 		$61K Buy
+1,784
New +$104K ﹤0.01% 2910

Other funds holding TCON

GPFA
Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Two Sigma Investments's TCON Position: Q2 2024 in Review

Two Sigma Investments sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 1,741 shares — an estimated $15K sold.

Two Sigma Investments first reported a position in TCON in Q1 2020 and held it in 11 quarters. The position peaked at $2.86M in Q4 2020. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

  • Two Sigma Investments reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 1,741 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $15K.
  • Two Sigma Investments first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Two Sigma Investments's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2.86M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.